Medtronic’s respiratory, gastrointestinal and renal revenue decreased 16 percent in the second quarter of fiscal year 2023, according to earnings results released on Nov. 22.
Medtronic GI revenue decreased by 16% in Q2
Medtronic’s respiratory, gastrointestinal and renal revenue decreased 16 percent in the second quarter of fiscal year 2023, according to earnings results released on Nov. 22.